February

February 16, 2015

Molecular therapy for Visceral pain: Menin (MEN1) decreases visceral pain in patients with Irritable Bowel Syndrome via up regulation of its target gene, 16/February/2015, 23.07

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, Molecular therapy for Visceral pain: Menin (MEN1) decreases visceral pain in patients with Irritable Bowel Syndrome […]
February 16, 2015

Regulation of miRNA biogenesis: Neurotensin suppresses the expression of Drosha, a component of miRNA processing machinery, via up regulation of its target gene, 16/February/2014, 22.56

A study from the Center for Cancer and Immunology Research, Children’s National Medical Center, Washington, DC 20010, USA; and others shows that “An mTORC1-Mdm2-Drosha Axis for miRNA Biogenesis in Response […]
February 16, 2015

MiRNA-based therapy for Ovarian tumors: MiRNA-497 increases the expression of tumor suppressor p53 via down regulation of its target gene, 16/February/2015, 22.33

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, MiRNA-based therapy for Ovarian tumors: MiRNA-497 increases the expression of tumor suppressor p53 via down regulation of […]
February 16, 2015

Natural product-based therapy for Visceral pain: Cucurbitacin I (JSI-124) decreases visceral pain in patients with Irritable Bowel Syndrome via up regulation of its target gene, 16/February/2015, 10.01 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, Natural product-based therapy for Visceral pain: Cucurbitacin I (JSI-124) decreases visceral pain in patients with Irritable […]